FDA willing to fast track coronavirus vaccine before phase three trials end
The chief of the U.S. Food and Drug Administration told the Financial Times that he is willing to bypass the standard approval process in order to make a Covid-19 vaccine available as soon as possible.
The chief of the U.S. Food and Drug Administration told the Financial Times that he is willing to bypass the standard approval process in order to make a Covid-19 vaccine available as soon as possible.
